C. Bacoyiannis

Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study

Haralabos P. Kalofonos, Gerasimos Aravantinos, P. Kosmidis et al. · Annals of Oncology · 2005 · 83 citations · Full text

Medicine, Oncology, Pharmacology +11

Conservative Approach to the Treatment of Chemotherapy‐Induced Extravasation

N. Tsavaris, P. Karagiaouris, Ifigeneia Tzannou et al. · The Journal of Dermatologic Surgery and Oncology · 1990 · 49 citations

Medicine, Oncology, Surgery +13

Gemcitabine versus Gemcitabine–Carboplatin for Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2: A Prospective Randomized Phase II Study of the Hellenic Cooperative Oncology Group

P. Kosmidis, Meletios Α. Dimopoulos, Konstantinos Syrigos et al. · Journal of Thoracic Oncology · 2007 · 42 citations · Full text

Medicine, Oncology, Chemotherapy +10

Gemcitabine versus Gemcitabine???Carboplatin for Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2: A Prospective Randomized Phase II Study of the Hellenic Cooperative Oncology Group

P. Kosmidis, Meletios Α. Dimopoulos, Konstantinos Syrigos et al. · Journal of Thoracic Oncology · 2007 · 21 citations

Medicine, Oncology, Chemotherapy +11

The prognostic significance of immune changes in patients with renal cell carcinoma treated with interferon alfa-2b.

P. Kosmidis, Constantin N. Baxevanis, Nick B. Tsavaris et al. · Journal of Clinical Oncology · 1992 · 19 citations

Medicine, Immunology, Oncology +17